Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: A comparative molecular field analysis study

Journal of Medicinal Chemistry

Volumn 40, Issue 5, 1997, Pages 739-748

  Sicsic, Sames ^a   Serraz, Isabelle ^a   Andrieux, Jean ^a   Brémont, Béatrice ^a   Mathé Allainmat, Monique ^a   Poncet, Annie ^a   Shen, Shuren ^a   Langlois, Michel ^a  

^a UNIVERSITÉ PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; MELATONIN RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; HORMONE RECEPTOR INTERACTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0031052115     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm960680+     Document Type: Article

References (39)

1. Reiter, R. J. Pineal Melatonin: Cell Biology of its Synthesis and its Physiological Interactions. Endocr. Rev. 1991, 12, 151-180.
2. Arendt, J. Melatonin and the Human Circadian System. In Melatonin, clinical perspectives; Miles, A., Philbrick, D. R. S., Thompson, C., Eds.; Oxford University Press: Oxford, 1988; pp 43-61.
3. Utiger, R. D. Melatonin - The Hormone of Darkness. N. Engl. J. Med. 1992, 327, 1377-1379.
4. Reiter, R. J. Neuroendocrinology of Melatonin. In Melatonin, clinical perspectives; Miles, A., Philbrick, D. R. S.; Thompson, C., Eds.; Oxford University Press: Oxford, 1988; pp 1-42.
5. Reiter, R. J. The Melatonin Rhythm, both a Clock and a Calendar, Experientia 1993, 49, 654-664.
6. Palm L.; Blennow, G.; Wetterberg, L. Correction of non-24 Hour/ Sleep/Wake Cycle by Melatonin in a Blind Retarded Boy. Annal. Neurol. 1991, 29, 336-339.
7. Dahlitz, M.; Alvarez, B.; Vignau, J.; English, J.; Arendt, J.; Parkes, J. D. Delayed Sleep Phase Syndrome Response to Melatonin. Lancet 1991, 331, 1121-1123.
8. Haimov, I.; Peretz, L.; Laudon, M.; Herer, P.; Vigder, C.; Zisapel, N. Melatonin Replacement Therapy of Elderly Insomniacs. Sleep 1995, 18, 598-603.
9. Maestroni, G. J. M. The Immunoneuroendocrine Role of Melatonin. J. Pineal Res. 1993, 14, 1-10.
10. Poeggeler, B.; Reiter, R. J.; Tan, D.-X.; Chen, L.-D.; Manchester, L. C. Melatonin, Hydroxy Radical-Mediated Oxidative Damage, and Aging: a Hypothesis. J. Pineal Res. 1993, 14, 151-158.
11. Morgan, P. J.; Lawson, W.; Davidson, G.; Howell, H. E. Guanine Nucleotides Regulate the Affinity of Melatonin Receptors on the Ovine Pars Tuberalis. Neuroendocrinology 1989, 50, 359-362.
12. Sugden, D. Melatonin: Binding Site Characteristics and Biochemical and Cellular Responses. Neurochem. Int. 1994, 24, 147-157.
13. Ebisawa, T.; Karne, S.; Lerner, M. R.; Reppert, S. M. Expression Cloning of a High-Affinity Melatonin Receptor from Xenopus Dermal Melanophores. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 6133-6137.
14. (a) Reppert, S. M.; Weaver, D. R.; Ebisawa, T. Cloning and Characterization of a Mammalian Melatonin Receptor that Mediates Reproductive and Circadian Responses. Neuron 1994, 13, 1177-1185.
15. 1b Melatonin Receptor. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 8734-8738.
16. (c) Reppert, S. M.; Weaver, D. R.; Cassone, V. M.; Godson, C. D; Kolakowski, L. F., Jr. Melatonin Receptors are for the Birds: Molecular Analysis of two Receptor Subtypes Differentially Expressed in Chick Brain. Neuron 1995, 15, 1003-1015.
17. (a) Heward, C. B.; Hadley, M. E. Structure Activity-Relationships of Melatonin and Related Indoleamines. Life Sci. 1975, 17, 1167-1177.
18. (b) Spadoni, G.; Stankov, B.; Duranti, A.; Biella, G.; Lucini, V.; Salvatori, A.; Fraschini, F. 2-Substituted 5-methoxy N-acyltryptamines: Synthesis, Binding Affinity for the Melatonin Receptor, and Evaluation of the Biological Activity. J. Med. Chem. 1993, 36, 4069-4074.
19. (c) Garratt, P. J.; Jones, R.; Rowe, S. J.; Sugden, D. Mapping the Melatonin Receptor. 1. The 5-Methoxyl Group of Melatonin is not an Essential Requirement for Biological Activity. Bioorg. Med. Chem. Lett. 1994, 4, 1555-1558.
20. (d) Garratt, P. J.; Jones R.; Tocher, D. A.; Sugden, D. Mapping the Melatonin Receptor. 3. Design and Synthesis of Melatonin Agonists and Antagonists Derived from 2-Phenyltryptamines. J. Med. Chem. 1995, 38, 1132-1139.
21. (e) Garrat, P. J.; Vonhoff, S.; Rowe, S. J.; Sugden, D. Mapping the Melatonin Receptor. 2. Synthesis and Biological Activity of Indole Derived Melatonin Analogues with Restricted Conformations of the C-3 Amidoethane Side Chain. Bioorg. Med. Chem. Lett. 1994, 4, 1559-1564.
22. (f) Fraschini, F.; Stankov, B. New Molecules Active at the Melatonin Receptor Level. In The pineal gland and its hormones; Fraschini, F., Reiter, R. J., Stankov, B., Eds.; Plenum Press: New York and London, 1995; pp 131-138.
23. (a) Yous, S.; Andrieux, J.; Howell, H. E.; Morgan, P. J.; Renard, P.; Pfeiffer, B.; Lesieur, D.; Guardiola-Lemaitre, B. Novel Naphthalenic Ligands with High Affinity for the Melatonin Receptor. J. Med. Chem. 1992, 35, 1484-1485.
24. (b) Depreux, P.; Lesieur, D.; Mansour, H. A.; Morgan, P.; Howell, H. E.; Renard, P.; Caignard, D-H.; Pfeiffer, B.; Delagrange, P.; Guardiola, B.; Yous, S.; Demarque, A.; Adam, G.; Andrieux, J. Synthesis and Structure-Activity Relationships of Novel Naphthalenic and Bioisosteric Related Amidic Derivatives as Melatonin Receptor Ligands. J. Med. Chem. 1994, 37, 3231-3239.
25. 125]Iodomelatonin Binding Sites. J. Med. Chem. 1995, 38, 2050-2060.
26. Jansen, J. M.; Karlén, A.; Grol, C. J.; Hacksell, U. Conformational Properties of Melatonin and two Conformationally Restricted Agonists: a Molecular Mechanics and NMR Spectroscopy Study. Drug Des. Discovery 1993, 10, 115-133.
27. Copinga, S.; Tepper, P. G.; Grol, C. J.; Horn, A. S.; Dubocovich, M. L. 2-Amido-8-methoxytetralins: A Series of Nonindolic Melatonin-like Agents. J. Med. Chem. 1993, 36, 2891-2898.
28. Sudgen, D.; Davies, D. J.; Garratt, P. J.; Jones, R.; Vonhoff, S. Radioligand Binding Affinity and Biological Activity of the Enantiomers of a Chiral Melatonin Analogue. Eur. J. Pharmacol. 1995, 287, 239-243.
29. Langlois M.; Mathé-Allainmat, M.; Renard, P.; Delagrange, Ph.; Guadiola-LeMaitre, B. French Patent 95 04503.
30. Mathé-Allainmat, M.; Gaudy, F.; Sicsic, S.; Dangy-Caye, A.-L.; Shen, S.; Bremont, B.; Benatalah, Z.; Langlois, M.; Renard, P.; Delagrange, Ph. Synthesis of 2-Amido-2,3-dihydro-1H-phenalene Derivatives as New Conformationally Restricted Ligands for Melatonin Receptors. J. Med. Chem. 1996, 39, 3089-3095.
31. Sugden, D.; Chong, N. W. S.; Lewis, D. F. V. Structural Requirements at the Melatonin Receptor. Br. J. Pharmacol. 1995, 114, 618-623.
32. Navajas, C.; Kokkola, T.; Poso, A.; Honka, N.; Gynther, J.; Laitinen, J. T. A Rhodopsin-based Model for Melatonin Recognition at its G-Protein Coupled Receptor. Eur. J. Pharmacol. 1996, 304, 173-183.
33. Grol, C. J.; Jansen, J. M. The High Affinity Melatonin Binding Site Probed with Conformationally Restricted Ligands-II. Homology Modeling of the Receptor. Bioorg. Med. Chem. 1996, 4, 1333-1339.
34. Cramer, R. D. III; Patterson, D. E.; Bunce, J. D. Comparative molecular field analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
35. Eliel, E. L.; Allinger, N. L.; Angyal, S. J.; Morrisson, G. A. Conformational Analysis; Intersciences Publishers: New York, 1965; pp 72-81.
36. Nicklaus, M. C.; Wang, S.; Driscoll, J. S.; Milne, G. W. A. Conformational Changes of Small Molecules Binding to Proteins. Bioorg. Med. Chem. 1995, 3, 411-428.
37. Thibaut, U.; Folkers, G.; Klebe, G.; Kubinyi, H.; Merz, A.; Rognan, D. Recommendations for CoMFA Studies and 3D QSAR Publications. In 3D QSAR and Drug Design. Theory Methods and Applications; Kubinyi, H., Ed.; Escom: Leiden, 1993; pp 711-716.
38. Waller, C. L.; Oprea, T. I.; Giolitti, A.; Marshall, G. R. Three Dimensional QSAR of Human Immunodeficiency Virus (I) Protease Inhibitors. 1. A CoMFA Study Employing Experimentally Determined Alignment Rules. J. Med. Chem 1993, 36, 4152-4160.
39. Jansen, J. M.; Copinga, S.; Gruppen, G.; Molinari, E. J.; Dubocovich, M. L.; Grol, C. J. The High Affinity Melatonin Binding Site Probed with Conformationally Restricted Ligands-I. Pharmacophore and Minireceptor Models. Bioorg Med. Chem. 1996, 4, 1332.